These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 28431569)

  • 1. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
    Skov M; McKay K; Koch C; Cooper PJ
    Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.
    Düesberg U; Wosniok J; Naehrlich L; Eschenhagen P; Schwarz C
    Sci Rep; 2020 Nov; 10(1):18999. PubMed ID: 33149181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.
    Fillaux J; Brémont F; Murris M; Cassaing S; Rittié JL; Tétu L; Segonds C; Abbal M; Bieth E; Berry A; Pipy B; Magnaval JF
    Scand J Infect Dis; 2012 Nov; 44(11):842-7. PubMed ID: 22831545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA).
    Skov M; Pressler T; Jensen HE; Høiby N; Koch C
    Thorax; 1999 Jan; 54(1):44-50. PubMed ID: 10343631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.
    Amin R; Dupuis A; Aaron SD; Ratjen F
    Chest; 2010 Jan; 137(1):171-6. PubMed ID: 19567494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
    Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH
    Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis.
    Murali PS; Pathial K; Saff RH; Splaingard ML; Atluru D; Kurup VP; Fink JN
    Chest; 1994 Aug; 106(2):513-9. PubMed ID: 7774329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
    Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
    Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
    Mastella G; Rainisio M; Harms HK; Hodson ME; Koch C; Navarro J; Strandvik B; McKenzie SG
    Eur Respir J; 2000 Sep; 16(3):464-71. PubMed ID: 11028661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
    Hughes DA; Archangelidi O; Coates M; Armstrong-James D; Elborn SJ; Carr SB; Davies JC
    J Cyst Fibros; 2022 Jan; 21(1):129-135. PubMed ID: 33958279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis.
    Gothe F; Kappler M; Griese M
    J Allergy Clin Immunol Pract; 2017; 5(6):1591-1598.e6. PubMed ID: 28526275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.
    Skov M; Koch C; Reimert CM; Poulsen LK
    Allergy; 2000 Jan; 55(1):50-8. PubMed ID: 10696856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
    Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
    BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.
    Ahlgren HG; Benedetti A; Landry JS; Bernier J; Matouk E; Radzioch D; Lands LC; Rousseau S; Nguyen D
    BMC Pulm Med; 2015 Jun; 15():67. PubMed ID: 26093634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy].
    Paul KD; Leupold W; Blaschke-Hellmessen R; Ulbrich K; Peter-Kern M; Neumeister V
    Mycoses; 1996; 39 Suppl 1():55-8. PubMed ID: 8767272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.